Tradeoffs Research Corner

We always strive to root our reporting in the latest and greatest data about what we know (and don’t know) when it comes to effective health policies. But there’s way more research coming out than we can fit in a weekly show. 

Enter the Research Corner newsletter. Each week, Tradeoffs reporter Soleil Shah offers original analysis, interviews with leading researchers and more to help you stay on top of the latest in health policy research. 

Explore our full archive of Research Corner content, including columns by prior contributors, below and sign up to get Research Corner delivered to your inbox every Tuesday. (It’s free!)

Past Research Corner Columns

Nursing Home Visits, Abortion and Intimate Partner Violence: More from ASHEcon

Soleil recaps two more fascinating studies from the 2023 ASHEcon conference.

Read More

New Insights into Racial and Ethnic Health Disparities

Soleil interviews health economist Jevay Grooms about the NBER’s 2023 Racial and Ethnic Health Disparities conference.

Read More

A Rare RCT of Artificial Intelligence in Medicine

A new randomized controlled trial in Nature shows the potential of artificial intelligence to help diagnose deadly heart conditions.

Read More

Should Remote Opioid Addiction Treatment Stay in the Mix?

Two recent studies show the impact of an ongoing, COVID-era rule that let doctors treat opioid addiction entirely remotely.

Read More

What the PHE Taught Us About Sick Leave, Telemedicine and Public Health Powers

A trio of studies help mark the end of the PHE, and recap some of the health policy lessons learned from this unprecedented period.

Read More

What we’ve learned from federal efforts to fight HIV/AIDS

A recent NBER working paper compares the impact of public health funding for HIV/AIDS to other federal programs.

Read More

Could ChatGPT Be Your New Health Coach?

A recent study finds ChatGPT answers everyday heart health questions accurately – most of the time.

Read More

A Closer Look at the Abortion Medication Mifepristone

What is the abortion drug at the center of a new legal maelstrom–and what happens if patients lose access to it?

Read More